Douglas J. Strathdee
Garscube Estate
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Characterisation of cold-selective lamina I spinal projection neurons in the mouse.
Journal: eLife
Published: May 13, 2026
Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 05, 2024
Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome.
Journal: International journal of molecular sciences
Published: November 13, 2024
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.
Journal: Nature
Published: September 03, 2024
Tafazzin regulates neutrophil maturation and inflammatory response.
Journal: EMBO reports
Published: August 06, 2024
Correction to: Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.
Journal: Cell death and differentiation
Published: August 02, 2024
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.
Journal: EMBO reports
Published: July 02, 2024
Plaat1 deficiency reduces cardiac cardiolipin content and impairs exercise tolerance.
Journal: Journal of lipid research
Published: June 27, 2024
Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse.
Journal: Nature biotechnology
Published: March 31, 2024
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.
Journal: Nature genetics
Published: February 08, 2024
Last Updated: 09/26/2026